Using GLP-1 agonists in high-risk individuals may delay or prevent the onset of obesity-related diseases
Results are as individualized as the treatment and will vary depending on which peptides you use, the dosage, and how your body responds to the treatment
Strategies to mitigate muscle loss include: Prioritizing protein at each meal before other macronutrients Incorporating resistance training at least 23 times weekly Monitoring body composition, not just scale weight Working with your healthcare provider if side effects prevent adequate nutritionnever adjust medication doses on your own Contact your healthcare provider immediately if you experience: Severe or persistent nausea, vomiting, or abdominal pain Signs of dehydration (extreme thirst, dizziness, dark urine) Low blood sugar symptoms (if taking insulin or sulfonylureas) Inability to eat or drink for more than 24 hours Selecting appropriate protein sources is essential for patients on GLP-1 therapy, particularly given the reduced appetite and early satiety these medications produce
Several agents also carry evidence for heart benefits, elevating them beyond strictly glycemic drugs
(Start sources from here) While your body makes its L-carnitine, it is also naturally found in food sources such as beef, pork, chicken, and dairy products
Trava's products are tirzepatide or semaglutide blended with vitamin B12 (cyanocobalamin)
